Abstract
Although an initial case series suggested that use of statins in pregnancy carried teratogenic risk, a recent meta-analysis of controlled observational studies has failed to corroborate this. A large number of potentially beneficial uses of statins in pregnant women have prompted a new evaluation of the risk-benefit ratio of these agents in pregnancy.
| Original language | English |
|---|---|
| Pages (from-to) | 506-509 |
| Number of pages | 4 |
| Journal | Journal of Obstetrics and Gynaecology Canada |
| Volume | 36 |
| Issue number | 6 |
| DOIs | |
| State | Published - 2014 |
| Externally published | Yes |
Keywords
- Cholesterol
- Congenital malformations
- Pregnancy
- Statins